Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Liabilities from Discontinued Operations: 2012-2013

  • Ani Pharmaceuticals' Liabilities from Discontinued Operations was N/A to $131,613 in Q3 2013 from the same period last year, while for Sep 2013 it was $131,613, marking a year-over-year change of. This contributed to the annual value of $370,766 for FY2012, which is N/A change from last year.
  • According to the latest figures from Q3 2013, Ani Pharmaceuticals' Liabilities from Discontinued Operations is $131,613, which was down 64.08% from $366,390 recorded in Q2 2013.
  • Ani Pharmaceuticals' Liabilities from Discontinued Operations' 5-year high stood at $370,766 during Q4 2012, with a 5-year trough of $131,613 in Q3 2013.
  • In the last 2 years, Ani Pharmaceuticals' Liabilities from Discontinued Operations had a median value of $366,390 in 2013 and averaged $289,590.